TACSTD2 and neoplasm: By binding to these targets, Trop2 affects tight junctions at the epithelial barrier [26]; increases tumor proliferation [34], podosome formation, and Raf and NF-kappa activation [11, 26]; and suppresses IGF-1R signaling [35].